The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31.
With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.
The following is a summary of “Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory ...
The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...
Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic dermatitis and delves into each option ...
Dermatitis refers to a number of skin conditions driven by inflammation, including atopic dermatitis (a type of eczema) and contact dermatitis. Dermatitis isn’t always curable, but it’s ...
Self-guided cognitive behavioral therapy was non-inferior in reducing atopic dermatitis symptom severity as clinician-guided ...
As everyone knows, scratching at chronically itchy skin only makes the problem worse. A new device is claimed to help stop ...
The best out-of-the-box tricks to treat atopic dermatitis (eczema), according to expert dermatologists, plus products to try.
Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
Atopic dermatitis is the most common chronic inflammatory skin disease globally. Key features include an eczematous eruption accompanied by intense itch, which can have an enormous negative effect on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback